https://www.selleckchem.com/pr....oducts/ulixertinib-b
218 implants on 142 patients. The survival rate of UKA was 94.7% at 10 years (95% CI 0.906-0.97, 80.9% at 20 years (95%CI 0.724-0.871), and 77.8% at 30 years (95%CI 0.669-0.855). The average grand total functional score increased from 61 (maximum 20 at 0 months to above 150 at ≥6 months. UKA is a good option for isolated medial compartment gonarthrosis with excellent functional outcome and good survivorship in selected patients. Single center experience, retrospective. We lost 6.0% of patients during follow-up.
Like
Comment
Share
